To investigate the mechanistic basis of the three-gene prognostic signature (EGR3, RECQL4, MMP1) in breast cancer progression, we performed differential expression analysis followed by GO and KEGG pathway enrichment analyses between the two molecular subtypes. This evidence concerns the gene RECQL4 and breast carcinoma.